Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells

被引:3
|
作者
Rosado-Galindo, Heizel [1 ]
Domenech, Maribella [1 ,2 ]
机构
[1] Univ Puerto Rico Mayaguez, Bioengn Program, Mayaguez, PR 00682 USA
[2] Univ Puerto Rico Mayaguez, Dept Chem Engn, Mayaguez, PR 00682 USA
基金
美国国家卫生研究院;
关键词
topography; EGFR signaling; TNBC; secretome; stemness; PHASE-II; TARGETED THERAPY; GROWTH; PROLIFERATION; RESISTANCE; PROMOTES; OVEREXPRESSION; CHALLENGES; SIGNATURE; YAP/TAZ;
D O I
10.3389/fcell.2023.1124250
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction: Cancer stem cells (CSC), a major culprit of drug-resistant phenotypes and tumor relapse, represent less than 2 % of the bulk of TNBC cells, making them difficult to isolate, study, and thus, limiting our understanding of the pathogenesis of the disease. Current methods for CSC enrichment, such as 3D spheroid culture, genetic modification, and stem cell conditioning, are time consuming, expensive, and unsuitable for high-throughput assays. One way to address these limitations is to use topographical stimuli to enhance CSC populations in planar culture. Physical cues in the breast tumor microenvironment can influence cell behavior through changes in the mechanical properties of the extracellular matrix (ECM). In this study, we used topographical cues on polystyrene films to investigate their effect on the proteome and stemness of standard TNBC cell lines.Methods: The topographical polystyrene-based array was generated using razor printing and polishing methods. Proteome data were analyzed and enriched bioprocesses were identified using R software. Stemness was assessed measuring CD44, CD24 and ALDH markers using flow cytometry, immunofluorescence, detection assays, and further validated with mammosphere assay. EGF/EGFR expression and activity was evaluated using enzyme-linked immunosorbent assay (ELISA), immunofluorescence and antibody membrane array. A dose-response assay was performed to further investigate the effect of surface topography on the sensitivity of cells to the EGFR inhibitor.Results: Surface roughness enriched the CSC population and modulated epidermal growth factor receptor (EGFR) signaling activity in TNBC cells. Enhanced proliferation of MDA-MB-468 cells in roughness correlated with upregulation of the epidermal growth factor (EGF) ligand, which in turn corresponded with a 3-fold increase in the expression of EGFR and a 42% increase in its phosphorylation compared to standard smooth culture surfaces. The results also demonstrated that phenotypic changes associated with topographical (roughness) stimuli significantly decreased the drug sensitivity to the EGFR inhibitor gefitinib. In addition, the proportion of CD44+/CD24-/ALDH+ was enhanced on surface roughness in both MDA-MB-231 and MDA-MB-468 cell lines. We also demonstrated that YAP/TAZ activation decreased in a roughness-dependent manner, confirming the mechanosensing effect of the topographies on the oncogenic activity of the cells.Discussion: Overall, this study demonstrates the potential of surface roughness as a culture strategy to influence oncogenic activity in TNBC cells and enrich CSC populations in planar cultures. Such a culture strategy may benefit high-throughput screening studies seeking to identify compounds with broader tumor efficacy.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer
    S Samanta
    V M Sharma
    A Khan
    A M Mercurio
    Oncogene, 2012, 31 : 4689 - 4697
  • [32] Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer
    Samanta, S.
    Sharma, V. M.
    Khan, A.
    Mercurio, A. M.
    ONCOGENE, 2012, 31 (44) : 4689 - 4697
  • [33] The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer
    Liu, Hui
    Paddock, Marcia N.
    Wang, Haibin
    Murphy, Charles J.
    Geck, Renee C.
    Navarro, Adrija J.
    Wulf, Gerburg M.
    Elemento, Olivier
    Haucke, Volker
    Cantley, Lewis C.
    Toker, Alex
    CANCER DISCOVERY, 2020, 10 (08) : 1226 - 1239
  • [34] Triple-Negative Breast Cancer
    Liedtke, Cornelia
    Schmutzler, Rita
    Schneeweiss, Andreas
    Loibl, Sybille
    Thill, Marc
    Heitz, Florian
    BREAST CARE, 2010, 5 (05) : 359 - 363
  • [35] Triple-negative breast cancer
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2020, 120 (08) : 22 - 23
  • [36] Triple-negative breast cancer
    Reinaldo D Chacón
    María V Costanzo
    Breast Cancer Research, 12
  • [37] The Functional Role of Notch Signaling in Triple-Negative Breast Cancer
    Speiser, Jodi J.
    Ersahin, Cagatay
    Osipo, Clodia
    HORMONES AND BREAST CANCER, 2013, 93 : 277 - 306
  • [38] Wnt signaling, triple-negative breast cancer, and green tea
    Yee, Amy S.
    Paulson, Kurtz Eric
    Castaner, Maricel
    Uong, Helen
    Minerva, Nora
    Wang, Kai
    Gilchrist, Kelsey
    Choi, Maria
    Sonenshein, Gail E.
    Baleja, Jim
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [39] Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
    Abderrahim El Guerrab
    Mahchid Bamdad
    Yves-Jean Bignon
    Frédérique Penault-Llorca
    Corinne Aubel
    Scientific Reports, 10
  • [40] Targeting Notch signaling in cancer stem-like cells of triple-negative breast cancer
    Murphy, Adrienne M.
    Ucar, Ayse D.
    Miele, Lucio
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)